Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
International Journal of Medical Sciences|July 28, 2020
HBx mediated Increase of SIRT1 Contributes to HBV-related Hepatocellular Carcinoma TumorigenesisQing Wang, Sheng-Tao Cheng, Juan ChenSheng Li Xue Bao : [Acta Physiologica Sinica]|May 6, 2025
[Crosstalk and the progression of hepatocellular carcinoma]Lei-Rong Gu, Hui Zhang, Juan Chen, et al.Biochemical and Biophysical Research Communications|January 26, 2018
HBx-elevated SIRT2 promotes HBV replication and hepatocarcinogenesisSheng-Tao Cheng, Ji-Hua Ren, Xue-Fei Cai, et al.Plos One|June 15, 2017
Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivoSheng-Tao Cheng, Hua Tang, Ji-Hua Ren, et al.International Journal of Medical Sciences|October 3, 2018
AGK2, A SIRT2 Inhibitor, Inhibits Hepatitis B Virus Replication In Vitro And In VivoHai-Bo Yu, Hui Jiang, Sheng-Tao Cheng, et al.Frontiers in Pharmacology|November 12, 2019
SIRT6 Inhibitor, OSS_128167 Restricts Hepatitis B Virus Transcription and Replication Through Targeting Transcription Factor Peroxisome Proliferator-Activated Receptors αHui Jiang, Sheng-Tao Cheng, Ji-Hua Ren, et al.International Journal of Medical Sciences|January 16, 2018
Interleukin-35 Level Is Elevated in Patients with Chronic Hepatitis B Virus InfectionSheng-Tao Cheng, Ding Yuan, Yi Liu, et al.Journal of Ethnopharmacology|April 1, 2020
Anti-hepatitis B virus activity of swertisin isolated from Iris tectorum MaximHong-Yan Xu, Ji-Hua Ren, Yu Su, et al.Journal of Experimental & Clinical Cancer Research : CR|February 7, 2024
RNA-binding protein RPS7 promotes hepatocellular carcinoma progression via LOXL2-dependent activation of ITGB1/FAK/SRC signalingYu-Jiao Zhou, Min-Li Yang, Xin He, et al.Cell Communication and Signaling : CCS|December 18, 2019
NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinomaHong-Zhong Zhou, Han-Qing Zeng, Ding Yuan, et al.Pageof 3